See more : Cera Sanitaryware Limited (CERA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of The Klinique Medical Clinic Public Company Limited (KLINIQ.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Klinique Medical Clinic Public Company Limited, a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
- BK Technologies Corporation (BKTI) Income Statement Analysis – Financial Results
- Thai Oil Public Company Limited (TOIPY) Income Statement Analysis – Financial Results
- Industria de Diseño Textil, S.A. (IXD1.DE) Income Statement Analysis – Financial Results
- MT Educare Limited (MTEDUCARE.BO) Income Statement Analysis – Financial Results
- Chang Wah Electromaterials Inc. (8070.TW) Income Statement Analysis – Financial Results
The Klinique Medical Clinic Public Company Limited (KLINIQ.BK)
About The Klinique Medical Clinic Public Company Limited
The Klinique Medical Clinic Public Company Limited provides skin care, cosmetic surgery, and holistic health care services in Thailand. Its services include face lift, acne, acne scars, shape up, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, Mesoface, and meso, as well as nose, eye, and facial surgery. The company is based in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.28B | 1.64B | 949.93M | 1.00B | 975.84M | 808.41M | 650.97M | 650.24M | 442.69M | 217.23M |
| Cost of Revenue | 1.05B | 716.07M | 391.16M | 406.55M | 437.14M | 384.81M | 509.65M | 466.42M | 366.07M | 181.97M |
| Gross Profit | 1.24B | 922.97M | 558.77M | 594.00M | 538.69M | 423.60M | 141.32M | 183.81M | 76.62M | 35.26M |
| Gross Profit Ratio | 54.05% | 56.31% | 58.82% | 59.37% | 55.20% | 52.40% | 21.71% | 28.27% | 17.31% | 16.23% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 274.97M | 214.83M | 125.04M | 147.78M | 0.00 | 0.00 | 103.61M | 102.32M | 121.10M | 74.01M |
| Selling & Marketing | 628.11M | 459.44M | 282.64M | 283.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 903.07M | 674.28M | 407.68M | 431.13M | 406.88M | 411.59M | 103.61M | 102.32M | 121.10M | 74.01M |
| Other Expenses | -13.20M | -7.06M | -2.15M | -6.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 889.88M | 667.22M | 405.53M | 425.06M | 406.88M | 411.59M | 103.61M | 102.32M | 121.10M | 74.01M |
| Cost & Expenses | 1.94B | 1.38B | 796.69M | 831.61M | 844.02M | 796.40M | 613.26M | 568.74M | 487.17M | 255.97M |
| Interest Income | 20.17M | 1.11M | 58.91K | 2.58M | 3.78M | 494.69K | 334.67K | 425.69K | 567.53K | 472.45K |
| Interest Expense | 15.10M | 10.66M | 4.32M | 5.93M | 346.53K | 220.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 194.61M | 142.00M | 81.19M | 77.32M | 74.53M | 60.34M | 41.98M | 35.45M | 25.58M | 16.24M |
| EBITDA | 559.93M | 329.00M | 205.17M | 210.04M | 220.75M | 75.44M | 79.69M | 116.94M | -18.90M | -22.51M |
| EBITDA Ratio | 24.50% | 24.34% | 24.69% | 24.87% | 21.15% | 8.95% | 12.24% | 17.98% | -4.27% | -10.36% |
| Operating Income | 345.16M | 255.75M | 153.24M | 168.94M | 131.82M | 12.01M | 37.71M | 81.49M | -44.48M | -38.75M |
| Operating Income Ratio | 15.11% | 15.60% | 16.13% | 16.88% | 13.51% | 1.49% | 5.79% | 12.53% | -10.05% | -17.84% |
| Total Other Income/Expenses | 5.06M | -9.55M | -4.26M | -3.35M | 14.05M | 2.87M | -334.67K | -425.69K | -567.53K | -472.45K |
| Income Before Tax | 350.22M | 246.20M | 148.98M | 165.60M | 145.87M | 14.88M | 37.37M | 81.07M | -45.05M | -39.22M |
| Income Before Tax Ratio | 15.33% | 15.02% | 15.68% | 16.55% | 14.95% | 1.84% | 5.74% | 12.47% | -10.18% | -18.05% |
| Income Tax Expense | 61.60M | 40.71M | 19.73M | 20.90M | 30.41M | -1.88M | 4.71M | 17.01M | 7.69M | 2.22M |
| Net Income | 288.62M | 205.49M | 129.26M | 144.69M | 115.46M | 16.76M | 32.66M | 64.06M | -31.92M | -12.16M |
| Net Income Ratio | 12.63% | 12.54% | 13.61% | 14.46% | 11.83% | 2.07% | 5.02% | 9.85% | -7.21% | -5.60% |
| EPS | 1.31 | 0.93 | 0.59 | 0.66 | 0.52 | 0.08 | 0.62 | 6.79 | -3.99 | -1.52 |
| EPS Diluted | 1.31 | 0.93 | 0.59 | 0.66 | 0.52 | 0.08 | 0.62 | 6.79 | -3.99 | -1.52 |
| Weighted Avg Shares Out | 220.00M | 220.00M | 220.00M | 220.00M | 220.00M | 220.00M | 52.96M | 9.44M | 8.00M | 8.00M |
| Weighted Avg Shares Out (Dil) | 220.00M | 220.00M | 220.00M | 220.00M | 220.00M | 220.00M | 52.96M | 9.44M | 8.00M | 8.00M |
Source: https://incomestatements.info
Category: Stock Reports